Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 11, 2025 10:00 ET | Source: Allegro NV

Allegro demonstrates safety profile of osteoarthritis hydrogel in data presentation at World Congress on Osteoporosis

Allegro’s microparticle hydrogel hydrocelin has the potential to be a first-in-class disease-modifying injectable treatment for osteoarthritisPreclinical study to be presented at WCO conference...
March 25, 2025 03:30 ET | Source: Allegro NV

Allegro’s injectable osteoarthritis treatment generates positive safety results in preclinical studies

Microparticle hydrogel shows clean systemic toxicity profile over 4 weeks and 13 weeks Treatment designed to restore shock-absorbing capacities of joints in osteoarthritisAllegro plans to start...
March 04, 2025 02:30 ET | Source: Allegro NV

Allegro reports positive safety data for its injectable osteoarthritis treatment in three preclinical studies

Hydrocelin is potentially a first-in-class disease-modifying injectable treatment for osteoarthritisPivotal clinical trial in osteoarthritis patients on track to start in 2025 Liege, Belgium – 4...
December 11, 2024 01:30 ET | Source: Allegro NV

Allegro’s osteoarthritis injectable shock absorbing gel demonstrates preclinical safety

Clean systemic toxicity profile and no local side-effects following injection Tiny shock absorbing microparticles support and enhance synovial fluidDesigned as potential first-in-class...